progesterone: is prescribed

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents hormone
Weight: 0.73
, drug
Weight: 0.57
, ingredient
Weight: 0.56
, substance
Weight: 0.55
Siblings estrogen
Weight: 0.39
, glucocorticoid
Weight: 0.39
, oxytocin
Weight: 0.39
, vasopressin
Weight: 0.38
, prolactin
Weight: 0.38

Related properties

Property Similarity
is prescribed 1.00
be prescribed after iui 0.97
be prescribed in pregnancy 0.89
be prescribed during pregnancy 0.88
be prescribed in early pregnancy 0.86
be prescribed during menopause 0.81

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.57
Rule weight: 0.66
Evidence weight: 0.85
Similarity weight: 1.00
Evidence: 0.43
Plausible(drug, is prescribed)
Evidence: 0.26
¬ Typical(progesterone, is prescribed)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.43
¬ Plausible(drug, is prescribed)

Remarkability exclusitivity betweem a parent and a child

0.12
Rule weight: 0.58
Evidence weight: 0.20
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(progesterone, is prescribed)
Evidence: 0.88
¬ Remarkable(drug, is prescribed)

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.36
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(progesterone, is prescribed)
Evidence: 0.71
¬ Remarkable(oxytocin, is prescribed)
0.03
Rule weight: 0.13
Evidence weight: 0.26
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(progesterone, is prescribed)
Evidence: 0.82
¬ Remarkable(estrogen, is prescribed)

Remarkability from parent implausibility

0.41
Rule weight: 0.42
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.43
Plausible(drug, is prescribed)
Evidence: 0.90
Remarkable(progesterone, is prescribed)
Evidence: 0.44
¬ Plausible(progesterone, is prescribed)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.82
Remarkable(estrogen, is prescribed)
Evidence: 0.56
¬ Plausible(estrogen, is prescribed)
0.55
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.71
Remarkable(oxytocin, is prescribed)
Evidence: 0.54
¬ Plausible(oxytocin, is prescribed)

Salient implies Plausible

0.18
Rule weight: 0.28
Evidence weight: 0.62
Similarity weight: 1.00
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.67
¬ Salient(progesterone, is prescribed)

Similarity expansion

0.77
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.97
Evidence: 0.90
Remarkable(progesterone, is prescribed)
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
0.70
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.89
Evidence: 0.90
Remarkable(progesterone, is prescribed)
Evidence: 0.84
¬ Remarkable(progesterone, be prescribed in pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.86
Evidence: 0.90
Remarkable(progesterone, is prescribed)
Evidence: 0.60
¬ Remarkable(progesterone, be prescribed in early pregnancy)
0.69
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.88
Evidence: 0.90
Remarkable(progesterone, is prescribed)
Evidence: 0.86
¬ Remarkable(progesterone, be prescribed during pregnancy)
0.64
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.81
Evidence: 0.90
Remarkable(progesterone, is prescribed)
Evidence: 0.79
¬ Remarkable(progesterone, be prescribed during menopause)
0.57
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.97
Evidence: 0.67
Salient(progesterone, is prescribed)
Evidence: 0.95
¬ Salient(progesterone, be prescribed after iui)
0.55
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.88
Evidence: 0.67
Salient(progesterone, is prescribed)
Evidence: 0.82
¬ Salient(progesterone, be prescribed during pregnancy)
0.55
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.89
Evidence: 0.67
Salient(progesterone, is prescribed)
Evidence: 0.85
¬ Salient(progesterone, be prescribed in pregnancy)
0.51
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.86
Evidence: 0.67
Salient(progesterone, is prescribed)
Evidence: 0.92
¬ Salient(progesterone, be prescribed in early pregnancy)
0.49
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.88
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.61
¬ Plausible(progesterone, be prescribed during pregnancy)
0.48
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.81
Evidence: 0.67
Salient(progesterone, is prescribed)
Evidence: 0.93
¬ Salient(progesterone, be prescribed during menopause)
0.48
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.89
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.67
¬ Plausible(progesterone, be prescribed in pregnancy)
0.47
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.88
Evidence: 0.26
Typical(progesterone, is prescribed)
Evidence: 0.50
¬ Typical(progesterone, be prescribed during pregnancy)
0.43
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.89
Evidence: 0.26
Typical(progesterone, is prescribed)
Evidence: 0.59
¬ Typical(progesterone, be prescribed in pregnancy)
0.42
Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.97
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.86
¬ Plausible(progesterone, be prescribed after iui)
0.38
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.81
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.80
¬ Plausible(progesterone, be prescribed during menopause)
0.38
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.86
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.86
¬ Plausible(progesterone, be prescribed in early pregnancy)
0.29
Rule weight: 0.85
Evidence weight: 0.42
Similarity weight: 0.81
Evidence: 0.26
Typical(progesterone, is prescribed)
Evidence: 0.78
¬ Typical(progesterone, be prescribed during menopause)
0.29
Rule weight: 0.85
Evidence weight: 0.35
Similarity weight: 0.97
Evidence: 0.26
Typical(progesterone, is prescribed)
Evidence: 0.87
¬ Typical(progesterone, be prescribed after iui)
0.24
Rule weight: 0.85
Evidence weight: 0.32
Similarity weight: 0.86
Evidence: 0.26
Typical(progesterone, is prescribed)
Evidence: 0.91
¬ Typical(progesterone, be prescribed in early pregnancy)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.67
Salient(progesterone, is prescribed)
Evidence: 0.26
¬ Typical(progesterone, is prescribed)
Evidence: 0.90
¬ Remarkable(progesterone, is prescribed)

Typical implies Plausible

0.41
Rule weight: 0.48
Evidence weight: 0.85
Similarity weight: 1.00
Evidence: 0.44
Plausible(progesterone, is prescribed)
Evidence: 0.26
¬ Typical(progesterone, is prescribed)

Typicality and Rermarkability incompatibility between a parent and a child

0.37
Rule weight: 0.51
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(progesterone, is prescribed)
Evidence: 0.31
¬ Typical(drug, is prescribed)

Typicality and Rermarkability incompatibility between siblings

0.08
Rule weight: 0.14
Evidence weight: 0.57
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(progesterone, is prescribed)
Evidence: 0.47
¬ Typical(estrogen, is prescribed)
0.07
Rule weight: 0.14
Evidence weight: 0.53
Similarity weight: 1.00
Evidence: 0.90
¬ Remarkable(progesterone, is prescribed)
Evidence: 0.52
¬ Typical(oxytocin, is prescribed)

Typicality inheritance from parent to child

0.37
Rule weight: 0.48
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.26
Typical(progesterone, is prescribed)
Evidence: 0.31
¬ Typical(drug, is prescribed)